HomeVLA • EPA
Follow
Valneva SE
Previous close
€3.62
Day range
€3.48 - €3.62
Year range
€2.95 - €7.75
Market cap
497.46M EUR
Avg Volume
603.52K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
In the news
Financials
Income Statement
Revenue
Net income
(EUR) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 38.07M | -75.70% |
Operating expense | -10.12M | -216.93% |
Net income | -34.22M | -147.26% |
Net profit margin | -89.90 | -294.46% |
Earnings per share | -0.54 | -224.54% |
EBITDA | -10.64M | -111.18% |
Effective tax rate | -8.48% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 171.25M | -34.40% |
Total assets | 520.54M | -25.43% |
Total liabilities | 363.02M | -31.90% |
Total equity | 157.52M | — |
Shares outstanding | 135.26M | — |
Price to book | 3.12 | — |
Return on assets | -7.05% | — |
Return on capital | -10.84% | — |
Cash Flow
Net change in cash
(EUR) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -34.22M | -147.26% |
Cash from operations | -71.40M | 20.03% |
Cash from investing | 2.36M | 136.40% |
Cash from financing | 35.61M | 114.21% |
Net change in cash | -33.16M | 55.90% |
Free cash flow | -70.84M | -56.18% |
About
Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Founded
2013
Website
Employees
684